{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-002057","form_type":"8-K","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2025-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.318037+00:00","generated_at":"2026-05-23T19:33:52.945339+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Predictive Oncology ends merger talks with Renovaro; LOI expired March 31, 2025","bullets":["POAI discontinued discussions with Renovaro (RENB) regarding proposed merger; LOI expired March 31, 2025.","POAI denies entering into a binding merger agreement; contradicts RENB's April 4, 2025 press release.","Extension agreement extended LOI term to March 31, 2025; POAI has no further obligations to RENB.","POAI reaffirms commitment to AI-driven drug discovery and drug development."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-002057","json":"https://secwatch.observer/filing/0001171843-25-002057.json","markdown":"https://secwatch.observer/filing/0001171843-25-002057.md","text":"https://secwatch.observer/filing/0001171843-25-002057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184325002057/0001171843-25-002057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184325002057/f8k_040725.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T19:33:52.945339+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}